APA

Bocket L., Peytavin G., Alidjinou E. K., Ajana F., Choisy P., Lê M., Charpentier C., Descamps D., Yazdanpanah Y., Katlama C., Simon A., Calvez V., Marcelin A. & Soulie C. (20170818). Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients. : The Journal of antimicrobial chemotherapy.

Chicago

Bocket L, Peytavin G, Alidjinou E K, Ajana F, Choisy P, Lê M, Charpentier C, Descamps D, Yazdanpanah Yazdan, Katlama C, Simon A, Calvez V, Marcelin A-G and Soulie C. 20170818. Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients. : The Journal of antimicrobial chemotherapy.

Harvard

Bocket L., Peytavin G., Alidjinou E. K., Ajana F., Choisy P., Lê M., Charpentier C., Descamps D., Yazdanpanah Y., Katlama C., Simon A., Calvez V., Marcelin A. and Soulie C. (20170818). Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients. : The Journal of antimicrobial chemotherapy.

MLA

Bocket L, Peytavin G, Alidjinou E K, Ajana F, Choisy P, Lê M, Charpentier C, Descamps D, Yazdanpanah Yazdan, Katlama C, Simon A, Calvez V, Marcelin A-G and Soulie C. Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients. : The Journal of antimicrobial chemotherapy. 20170818.